June, 2024
DOD Translational Team Science Award, a new grant, funded!
Jun. 21, 2024—We will determine if we can predict the ability of pyrvinium to reprogram the gastric mucosa using patient-derived pre-cancer organoids. Also, we will initiate a clinical trial to evaluate the ability of a 2-week treatment with pyrvinium to reprogram metaplasia in a high-risk diverse population at Duke University in North Carolina. Grant funds research for therapies...